Cantabio Pharmaceuticals ^Company

Neurodegenerative diseases. CANTABio’s research is focused on reducing the harmful effects of biochemical stress, preventing and slowing resulting diseases through developing novel disease modifying therapeutics for neurodegeneration and metabolic conditions.